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Abstract The endosome-associated cargo adaptor sorting nexin-27 (SNX27) is linked to various
neuropathologies through sorting of integral proteins to the synaptic surface, most notably AMPA
receptors. To provide a broader view of SNX27-associated pathologies, we performed proteomics
in rat primary neurons to identify SNX27-dependent cargoes, and identified proteins linked to
excitotoxicity, epilepsy, intellectual disabilities, and working memory deficits. Focusing on the
synaptic adhesion molecule LRFN2, we established that SNX27 binds to LRFN2 and regulates its
endosomal sorting. Furthermore, LRFN2 associates with AMPA receptors and knockdown of
LRFN2 results in decreased surface AMPA receptor expression, reduced synaptic activity, and
attenuated hippocampal long-term potentiation. Overall, our study provides an additional
mechanism by which SNX27 can control AMPA receptor-mediated synaptic transmission and
plasticity indirectly through the sorting of LRFN2 and offers molecular insight into the perturbed
function of SNX27 and LRFN2 in a range of neurological conditions.
Introduction
The endosomal network plays a central role in controlling the functionality of the cell surface through
orchestrating the sorting of endocytosed integral proteins between two fates: either degradation
within the lysosome or retrieval from degradation for active recycling back to the plasma membrane
(Cullen and Steinberg, 2018). While the molecular details of sorting to the degradative fate are rel-
atively well described, only recently, with the identification of sorting nexins (Kurten et al., 1996;
Stockinger et al., 2002; Joubert et al., 2004; Carlton et al., 2004; Strochlic et al., 2007;
Harterink et al., 2011), retromer (Seaman et al., 1998), retriever (McNally et al., 2017), and the
WASH, CCC and ESCPE-1 complexes (Derivery et al., 2009; Gomez and Billadeau, 2009; Phillips-
Krawczak et al., 2015; Simonetti et al., 2019), have the core and evolutionarily conserved sorting
complexes that orchestrate retrieval and recycling begun to be identified. Importantly, an increasing
body of clinical evidence is linking mutations in these sorting complexes with a variety of human
pathologies, most notably neurological diseases and disorders, metabolic conditions and pathogen
infections (Cullen and Steinberg, 2018). With the notable exception of defects in the CCC complex-
mediated retrieval and recycling of low-density lipoprotein (LDL) receptor and the clearance of circu-
lating LDL-cholesterol during hypercholesterolaemia and atherosclerosis (Bartuzi et al., 2016;
Fedoseienko et al., 2018), how defects in the cell surface proteome, that arise from perturbed
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endosomal sorting, relate to the aetiology of these complex disorders remains poorly understood. A
case in point is sorting nexin-27 (SNX27), in which destabilised expression is associated with Down’s
Syndrome and coding mutations are observed in patients with pleomorphic phenotypes that have at
their core epilepsy, developmental delay and subcortical white matter abnormalities (Damseh et al.,
2015; Parente et al., 2020; Wang et al., 2013).
SNX27 is unique within the sorting nexin family in that it contains an amino-terminal PSD-95, Disc-
large and ZO-1 (PDZ) domain. This serves a bifunctional role mediating two mutually exclusive pro-
tein:protein interactions: first, the binding to the heterotrimeric retromer complex (Gallon et al.,
2014; Steinberg et al., 2013); and secondly, the binding to a specific type of PDZ domain-binding
motif located at the carboxy-terminus of an array of integral proteins (Cullen, 2008;
Steinberg et al., 2013; Lauffer et al., 2010; Temkin et al., 2011). Through these interactions
SNX27 regulates the retromer-dependent retrieval of internalised integral proteins that contain the
specific PDZ domain-binding motif and promotes their recycling to the plasma membrane
(Lauffer et al., 2010; Temkin et al., 2011; Steinberg et al., 2013).
The identification and functional validation of a handful of neuronal integral proteins that rely on
SNX27 for their trafficking has provided some insight into the complex aetiology of SNX27-associ-
ated pathology. These proteins include a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) receptors (Wang et al., 2013; Hussain et al., 2014; Loo et al., 2014), N-methyl-D-aspartate
(NMDA) receptors (Cai et al., 2011), serotonin (5-HT) receptors (Joubert et al., 2004) and the G
protein–activated inward rectifying potassium channels (GIRK/Kir3) (Lunn et al., 2007). From studies
in SNX27 knockout mice, it is clear that SNX27 is required to maintain AMPA-receptor-mediated
postsynaptic currents during the process of synaptic plasticity (Wang et al., 2013; Loo et al., 2014;
Cai et al., 2011). Indeed, the de-regulation of SNX27 expression associated with Down’s syndrome
(Wang et al., 2013), is considered to lead to synaptic dysfunction, in part, through reduced SNX27-
mediated AMPA receptor trafficking. SNX27 therefore plays a pivotal role in the endosomal sorting
of AMPA receptors. The current dogma describing SNX27-mediated AMPA receptor sorting relies
upon the direct binding of the PDZ binding motif presented at the carboxy-termini of AMPA recep-
tor subunits to the PDZ domain of SNX27. However, using isothermal titration calorimetry Clairfeuille
and colleagues were unable to detect quantifiable binding of SNX27 to the AMPA receptor subunits
GluA1 and GluA2. Moreover, the authors failed to observe binding upon GluA1 phosphorylation, or
upon association of SNX27 with the retromer component VPS26, which is known to enhance SNX27
binding to other PDZ binding motif-containing cargoes (Clairfeuille et al., 2016). These data sug-
gest a need to reflect on the molecular details of SNX27-mediated endosomal sorting of AMPA
receptors.
Here, using unbiased proteomics, we define the SNX27 interactome in primary rat cortical neu-
rons and describe the identification of new SNX27-dependent neuronal cargo. Many of these inte-
gral proteins provide further molecular insight into the underlying neuronal de-regulation associated
with SNX27-associated pathologies. In particular, we functionally validate one specific cargo, the syn-
aptic adhesion molecule leucine-rich repeat and fibronectin type-III domain containing protein 2
(LRFN2). We identify that SNX27 directly associates with the carboxy-terminal PDZ binding motif of
LRFN2, while the amino-terminal region of LRFN2 associates with AMPA receptors. Functionally,
SNX27 is required for the cell surface recycling of endocytosed LRFN2 and AMPA receptors. By
establishing that LRFN2 knockdown also results in decreased surface expression of AMPA receptors
and, in ex vivo recordings, the reduction of synaptic activity and attenuation of hippocampal long-
term potentiation, we add to the known complexities of SNX27-mediated AMPA receptor endoso-
mal sorting by proposing a role for LRFN2 in bridging the indirect association of SNX27 with AMPA
receptors.
Results
A neuronal SNX27 interactome reveals new cargoes for SNX27-
mediated trafficking
To identify neuronal cargoes that depend on SNX27 for their trafficking, we took an unbiased prote-
omic approach to quantify the SNX27 interactome in primary rat cortical neuronal cultures. Here, we
transduced cortical neurons with sindbis virus expressing either GFP or GFP-SNX27 and verified that
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the GFP-SNX27 retained the ability to localise to endosomes as defined by co-localisation with the
early endosomal marker EEA1 (Figure 1A). After 24 hr, we performed GFP-nanotrap immunoisola-
tion followed by protein digestion and tandem mass tagging (TMT) of the resulting peptides. Inter-
actors were identified quantitatively using liquid chromatography-tandem mass spectrometry and
quantified across three independent biological repeats. A single list of SNX27-interacting proteins
(276 proteins) was initially resolved by excluding proteins not present in all three datasets
(Figure 1B and Supplementary file 1). We further refined these data by excluding proteins that had
an average log-fold change of GFP-SNX27:GFP of less than two and removed identified proteins if
they did not meet statistical significance (p<0.05). The resulting 212 proteins were considered to
comprise a high confidence cortical neuronal SNX27 interactome (Figure 1C and
Supplementary file 1).
Confirming the validity of our approach, many established SNX27 interactors were identified
including the retromer and WASH complexes (Steinberg et al., 2013) and OTU deubiquitinase with
linear linkage specificity (OTULIN) – a deubiquitinase with specificity for Met1-linked ubiquitin chains
(Stangl et al., 2019). We used gene ontology analysis (PANTHER Classification System; p < 0.05) to
assess the neuronal SNX27 interactome and found that many of the SNX27 interactors were classi-
fied in having a role in neuronal development and differentiation, as well as intracellular transport
(Figure 1D). Out of the 212 identified proteins sixteen contained a Type I PDZ binding motif with
the optimal acidic amino acid at the  3 position required for high-affinity binding to SNX27
(Clairfeuille et al., 2016). Within this cohort, seven proteins were classified as integral proteins
(shown in orange in Figure 1C and Supplementary file 1): the high-affinity glutamate transporter,
SLC1A3 (Storck et al., 1992) (PDZ binding motif – E 3-T-K-M 0) and the sodium bicarbonate co-
transporter, SLC4A7 (Thornell and Bevensee, 2015) (E 3-T-S-L 0); a sodium-dependent transporter,
SLC6A11 (Borden, 1996) (E 3-T-H-F 0); an outward rectifying potassium channel, KCNT2
(Bhattacharjee et al., 2003) (E 3-T-Q-L 0); a scaffold in neurotrophin signalling, KIDINS220
(Iglesias et al., 2000; Kong et al., 2001) (E 3-S-I-L 0); a receptor for the neuronal secreted protein
LGI1 (Fukata, 2006), ADAM22 (E 3-T-S-I 0), and LRFN2 (E 3-S-T-V 0), a protein previously impli-
cated in the synaptic clustering of glutamate receptors (Ko et al., 2006; Morimura et al., 2006;
Wang et al., 2006), and genetically associated with patients harbouring working memory deficits
(Thevenon et al., 2016).
Interestingly, we failed to classify any AMPA receptor subunits as components of the neuronal
SNX27 interactome. That said, GluA2 was quantified in one data set but did not fulfil the stringent
filtering criteria and hence was not annotated in the final interactome. This could reveal a weak, low
abundance association between SNX27 and GluA2, which may reflect an indirect mechanism of asso-
ciation. However, to independently examine the binding of SNX27 to the PDZ-binding motifs of
AMPA receptor subunits, we generated a series of amino-terminal GFP-tagged AMPA receptor
fusion proteins by cloning the carboxy-terminal tails of rat GluA1, GluA2, GluA3, and GluA4 into a
mammalian GFP expression vector. To act as positive controls, we also cloned the carboxy-terminal
tails of the high-affinity glutamate transporter SLC1A3 and the sodium bicarbonate co-transporter
SLC4A7. These two proteins contain an optimal motif for high-affinity binding to the SNX27 PDZ
domain as defined by an acidic residue at the  3 position of their Type I PDZ binding motif
(Clairfeuille et al., 2016; Figure 1E). The AMPA receptor PDZ binding motifs lack this optimal
sequence. Alongside the wild-type tails of SLC1A3 and SLC4A7, we also generated corresponding
PDZ binding motif mutants through removal of the last three carboxy-terminal amino acids. The
resulting series of plasmids were transiently transfected into human embryonic kidney (HEK293T)
cells prior to GFP-nanotrap immunoisolation and quantitative western blotting of the resulting pre-
cipitates. While both GFP-SLC1A3 and GFP-SLC4A7 efficiently pulled down endogenous SNX27, in
a manner dependent on their PDZ binding motifs (Figure 1F), we failed to observe detectable asso-
ciation of endogenous SNX27 with any of the GFP-tagged AMPA receptor subunits (Figure 1G).
To ensure that the lack of detectable binding did not arise from species cross reactivity, an
unlikely event given the high-sequence conservation between rat and human SNX27, we also per-
formed a series of co-immunoprecipitation experiments in HEK293T cells expressing the GFP-
tagged AMPA receptor carboxy-terminal tails and Flag-tagged full-length rat SNX27. Again, we
failed to observe a detectable association of AMPA receptor subunits with rat SNX27 (Figure 1—fig-
ure supplement 1). Finally, to examine whether SNX27 could potentially interact with AMPA recep-
tors specifically in the context of neurons we transduced primary rat cortical neuronal cultures with
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Figure 1. SNX27 interactome reveals new neuronal cargoes. (A) Immunofluorescence staining of endogenous early endosomal marker EEA1
(pseudocoloured in magenta) in DIV21 rat cortical neurons transduced with GFP or GFP-SNX27 expressing sindbis virus. Scale bars, 20 mm. White boxes
indicate the 20 mm section zoomed in. (B) TMT Interactome of SNX27 compared to the GFP control quantified across three independent experiments
(n = 3) in DIV21 rat cortical neurons. Plotted proteins were present in all three data sets and analysed using a one-sample t-test and Benjamini–
Figure 1 continued on next page
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sindbis virus expressing either GFP or GFP-SNX27. Twenty-four hr after transduction we carried out
GFP-nanotrap immunoisolation and quantitative western blotting for the endogenous AMPA recep-
tor subunits GluA1 and GluA2. Again, under these conditions, we failed to detect any association of
endogenous GluA1 or GluA2 with rat SNX27 (Figure 1H). Together these data are consistent with
the AMPA receptor PDZ binding motifs lacking the optimal sequence for high-affinity SNX27 binding
(Clairfeuille et al., 2016) and corroborate our proteomic data. Whilst our data do not exclude that
SNX27 may directly bind to AMPA receptors under specific circumstances, our data is more consis-
tent with the SNX27-dependent recycling of AMPA receptors being principally controlled by indirect
binding. Hence, we assessed the SNX27 interactome further, to identify any interactors that may
serve to ‘bridge’ the association of SNX27 with AMPA receptors. Of particular interest in this regard
was LRFN2, a protein known to be involved in synaptic clustering (Ko et al., 2006; Morimura et al.,
2006; Wang et al., 2006).
LRFNs interact with SNX27 through their PDZ-binding motifs
The LRFN family (also known as synaptic adhesion-like molecules [SALMs]) comprises five single
transmembrane spanning proteins, LRFN1 through to LRFN5, that each contain an extracellular
region of six leucine-rich repeats (LRR), an immunoglobulin (Ig) domain and a fibronectin type III
domain, but differ in their cytosolic facing carboxy-terminal tails with LRFN1, LRFN2, and LRFN4
containing a Type I PDZ binding motif (Lie et al., 2018; Seabold et al., 2008). Both LRFN1 and
LRFN4 were identified in the raw SNX27 proteomic data sets but were each filtered out from the
final high confidence interactome because they were not quantified across all three biological
repeats (Supplementary file 1). To validate the association of SNX27 with LRFN2, we cloned the
carboxy-terminal cytoplasmic tails of all five LRFNs into mammalian GFP expression vectors. Tran-
sient transfection into HEK293T cells followed by GFP-nanotrap immunoisolation of the GFP-LRFN
fusion proteins and quantitative western blotting revealed that only those LRFNs containing a PDZ
binding motif, LRFN1, LRFN2 and LRFN4, associated with endogenous SNX27 (Figure 2A). More-
over, each association was dependent on the presence of the corresponding PDZ binding motif as
deletion of the last three amino acids resulted in mutant LRFNs that failed to associate with SNX27
(Figure 2B).
The LRFN2 PDZ binding motif is defined by the sequence E 3-S 2-T 1-V0, where the valine resi-
due constitutes the carboxy-terminal amino acid. Mutation of the glutamic acid residue at the  3
position (LRFN2 (p.E786A)) or the carboxy-terminal valine (LRFN2 (p.V789A)) lead to the formation
of mutant proteins that each lost the ability to associate with SNX27 (Figure 2C). To define the
direct nature of the SNX27 PDZ domain binding to the LRFN2 PDZ binding motif, we turned to iso-
thermal titration calorimetry (ITC). This established that the isolated recombinant PDZ domain of
Figure 1 continued
Hochberg false-discovery rate (276 proteins). Vertical red line represents the threshold for enriched proteins in the SNX27 interactome (2) compared
to the GFP control. Horizontal red line represents the threshold for statistical analysis (p0.05). Pink circles are the protein interactors that are enriched
and meet statistical significance. Blue circles are the proteins that meet statistical significance but are not over twofold enriched. Grey circles are
interactions that are not statistically significant. (C) Filtered TMT interactome (212 proteins) showing only those proteins that were statistically significant
and over two log fold change. SNX27 is shown in green with retromer, and the WASH complex shown in blue. Transmembrane proteins that contain a
Type I PDZbm with the acidic residue at the  3 position are shown in orange. (D) Gene ontology analysis using the PANTHER classification system of
the filtered SNX27 interactome. (E) Schematic highlighting the last six amino acids of the C-terminal tails of isoform 1 of human GluA1, GluA2, GluA3,
GluA4, SLC1A3, and SLC4A7 (sequences are conserved in rat). Only SLC1A3 and SLC4A7 possess the optimal PDZ binding motif (PDZbm) consensus
sequence for high-affinity binding to SNX27 (highlighted in blue, j; hydrophobic amino acid). (F–H) Fluorescence-based western analysis after GFP-
Trap immunoprecipitation of the: (F) C-terminal tails of GFP-SLC1A3 and GFP-SLC4A7 (+/- PDZbm) with endogenous SNX27 in HEK293T cells.
Quantification from three independent experiments (n = 3). Data expressed as a percentage of the WT condition and analysed by an unpaired t-test.
Error bars represent mean ± SEM. ****, p0.0001; ***, p0.001. (G) C-terminal tails of AMPA receptors (GFP-GluA1-4) with endogenous SNX27 in
HEK293T cells. (H) Full-length GFP-SNX27 expressing sindbis virus with endogenous GluA1 or GluA2 in DIV20 rat cortical neurons.
The online version of this article includes the following source data and figure supplement(s) for figure 1:
Source data 1. Original immunoblots.
Source data 2. Data for Figure 1F.
Figure supplement 1. SNX27 does not directly interact with AMPA receptors.
Figure supplement 1—source data 1. Original immunoblots.
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Figure 2. LRFNs interact with SNX27 through their PDZ binding motifs. (A–C) Fluorescence-based western analysis after GFP-Trap
immunoprecipitation of: (A) the C-terminal tails of GFP-LRFN1-5 with endogenous SNX27 in HEK293T cells; (B) the C-terminal domains of LRFN1,
LRFN2, and LRFN4 (+/- PDZ binding motif (PDZbm)) with endogenous SNX27 in HEK293T cells. Quantification from three independent experiments (n
= 3). Data expressed as a percentage of the wild-type condition and analysed by an unpaired t-test; (C) the C-terminal domain of LRFN2 (+/- PDZbm
and mutants pE786A, pV789A) with endogenous SNX27 in HEK293T cells. Quantification from three independent experiments (n = 3). Data expressed
as a percentage of the wild-type condition and analysed by an unpaired t-test. (D) Binding of the LRFN2 peptide to the SNX27 PDZ domain, measured
by ITC either to SNX27 alone or in the presence of the retromer component VPS26. Top panel shows raw data and bottom panel shows integrated and
normalised data. (E) Fluorescence-based western analysis after GFP-Trap immunoprecipitation of full-length GFP-SNX27 with endogenous LRFN2 in
DIV20 rat cortical neurons. In all figures error bars represent mean ± SEM. ****, p0.0001.
The online version of this article includes the following source data for figure 2:
Source data 1. Original immunoblots.
Source data 2. Data for Figure 2B and C.
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SNX27 directly bound to a synthetic peptide corresponding to the LRFN2 PDZ binding motif, S-S-E-
W-V-M-E 3-S-T-V 0 with a high micromolar affinity (Kd = 1.6 mM) (Figure 2D). Moreover, the affinity
of this interaction was enhanced upon inclusion of recombinant VPS26 (Kd < 1.0 mM), a retromer
component that directly associates with the PDZ domain of SNX27 and has been previously shown
to enhance the binding affinity between the SNX27 PDZ domain and PDZ binding motif-containing
peptides (Gallon et al., 2014; Chan et al., 2016).
Finally, to confirm that endogenous LRFN2 also associated with SNX27, we transduced primary
rat cortical neuronal cultures with sindbis virus expressing either GFP or GFP-SNX27. GFP-nanotrap
immunoisolation and quantitative western blotting confirmed the association between SNX27 and
full-length endogenous LRFN2 (Figure 2E). Together these data establish that by means of its car-
boxy-terminal PDZ binding motif LRFN2 directly associates with the PDZ domain of SNX27. We also
suggest that this mode of interaction holds true for LRFN1 and LRFN4.
The membrane trafficking of LRFN2 is dependent on SNX27
To examine the functional importance of SNX27 binding to LRFN2, we transduced primary rat hip-
pocampal neuronal cultures with sindbis virus encoding for GFP-tagged SNX27 and mCherry-tagged
full-length LRFN2 (we were unable to identify antibodies suitable for detecting the expression of
endogenous SNX27 or endogenous LRFN2 by immunocytochemistry in these primary cultures). Con-
focal microscopy revealed that the endosome associated SNX27 (see Figure 1A) co-localised with
LRFN2 punctae throughout the neuron including in the dendrites and the cell body (Figure 3A). To
determine the role of SNX27 in the steady-state localisation of LRFN2, we transduced primary rat
cortical neuronal cultures with SNX27 shRNA or a non-targeting control shRNA (Binda et al., 2019).
Following 7 days of incubation, during which time the expression of endogenous SNX27 was
strongly suppressed (Figure 3B), we biochemically quantified the total cellular levels of endogenous
LRFN2 by western analysis. Similar to a wide array of other integral proteins that require endosomal
SNX27 for their retrieval away from the lysosomal degradative fate (Steinberg et al., 2013), the sup-
pression of SNX27 expression led to a robust reduction in the total cellular level of LRFN2 (an
approximate 50% reduction, n = 5, unpaired t-test, t (8) = 4.6, p = 0.0017) (Figure 3C). We also per-
formed restricted cell surface biotinylation and streptavidin affinity capture coupled with quantitative
western analysis to quantify the cell surface level of the AMPA receptor subunits, GluA1 and GluA2,
and LRFN2. Consistent with published studies (Hussain et al., 2014; Loo et al., 2014; Wang et al.,
2013), the suppression of SNX27 expression led to a clear reduction in the cell surface level of
GluA1 and GluA2 (an approximate 37% reduction for GluA1, n = 4, unpaired t-test, t (6) = 3.9, p =
0.0078; and an approximate 64% reduction for GluA2, n = 4, unpaired t-test, t (6) = 4.0, p = 0.0074)
(Figure 3D). Transferrin receptor levels were also measured as a control and were found to be
unchanged (n = 4, unpaired t-test, t (6) = 0.6, p = 0.5774) (Figure 3E). Importantly, under these con-
ditions, SNX27 suppression also induced a robust reduction in the cell surface level of LRFN2 (an
approximate 52% reduction, n = 6, unpaired t-test, t (10) = 5.0, p = 0.0006) (Figure 3F).
To assess further the trafficking of LRFN2, we analysed the internalisation of LRFN2 after suppres-
sion of SNX27 in the neuroglioma H4 cell line. After 6 days of culturing with either a control or
SNX27 shRNA, the cells were transfected with mCherry-LRFN2 and left for another 24 hr. Surface
LRFN2 was labelled using an mCherry antibody, to detect the exofacial expressed mCherry of the
LRFN2 fusion protein, and then allowed to internalise for 2 hr. After fixation and permeabilisation,
the cells were co-stained with LAMP2 to label lysosomes. To detect the mCherry antibody, we used
an Alexa Fluor 405 conjugated secondary antibody. The colocalisation between LRFN2 and LAMP2
significantly increased after SNX27 suppression (an approximate 27% increase, n = 30, unpaired
t-test, t (58) = 2.4, p = 0.0200) (Figure 3G). Together these data establish LRFN2 as an integral pro-
tein that conforms to the dogma of SNX27-mediated membrane trafficking in that it requires SNX27
for its retrieval from lysosomal degradation, a pre-requisite for recycling back to the cell surface.
LRFNs interact with AMPA receptors
The LRFN family of synaptic proteins are considered adhesion molecules that cluster receptors at
the synaptic surface (Ko et al., 2006; Morimura et al., 2006; Wang et al., 2006; Lie et al., 2018).
For LRFN2, research has principally focused on its ability to cluster NMDA receptors (Wang et al.,
2006). To define whether LRFN2 also plays a role in regulating AMPA receptor trafficking, we first
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Figure 3. The membrane trafficking of LRFN2 is dependent on SNX27. (A) Immunofluorescence staining of DIV20 rat hippocampal neurons co-
transduced with mCherry-LRFN2 (pseudocoloured in magenta) and GFP-SNX27 expressing sindbis viruses. Scale bars, 20 mm. White boxes indicate the
20 mm section zoomed in. Representative fluorescence intensity plot shown of the 20 mm zoomed in section from (i). (B–C) Fluorescence-based western
analysis of DIV19 rat cortical neurons transduced with either a control or SNX27 shRNA for: (B) endogenous SNX27 (C) endogenous LRFN2. Actin was
used as a protein load control. Quantification from five independent experiments (n = 5). Data expressed as a percentage of the control shRNA and
analysed by an unpaired t-test. (D–E) Fluorescence-based western analysis after surface biotinylation and streptavidin agarose capture of membrane
Figure 3 continued on next page
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examined the relative cell surface localisation of LRFN2 and AMPA receptors in neurons. Here, we
transduced primary rat hippocampal neuronal cultures with sindbis virus encoding mCherry-tagged
LRFN2 such that the mCherry tag was exofacially expressed. After 24 hr of expression, we observed
the surface localisation of LRFN2 and AMPA receptors by indirect immunofluorescence using an
mCherry antibody (and Alexa Fluor 647 labelled secondary antibody), and antibodies against extra-
cellular epitopes of the endogenous AMPA receptor subunits GluA1 and GluA2, followed by fixa-
tion. This revealed points of overlap between the distribution of cell surface LRFN2 and endogenous
GluA1 and GluA2 in dendrites (Figure 4A and B and C).
To investigate the possible association of LRFN proteins with AMPA receptors, we transiently co-
transfected HEK293T cells with full-length mCherry-tagged versions of LRFN1, LRFN2, or LRFN4 and
either full-length super-ecliptic pHluorin (SEP)-tagged GluA1 or GluA2. Twenty-four hr later GFP-
nanotrap immunoisolation (targeting the SEP tag) and western analysis revealed that LRFN1, LRFN2,
and LRFN4 were all able to associate with GluA1 and GluA2 (Figure 4D). To map the region respon-
sible for this interaction, we engineered a series of amino-terminal truncations of the extracellular
region of LRFN2 (Figure 4E). The resulting mCherry-tagged deletion mutants were transiently co-
transfected into HEK293T cells alongside either SEP-GluA1 or myc-GluA2 encoding vectors prior to
RFP-nanotrap immunoisolation (targeting the mCherry tag) and western analysis of associating pro-
teins. While full-length LRFN2 associated with GluA1 and GluA2, deletion of the LRR and Ig domains
led to a reduction in binding (an approximate 56% reduction for GluA1, n = 4, unpaired t-test, t (6)
= 3.3, p = 0.0173; and an approximate 67% reduction for GluA2, n = 4, unpaired t-test, t (6) = 10.6,
p = <0.0001) that was further reduced upon removal of the juxtamembrane fibronectin type III
domain (an approximate 79% reduction for GluA1, n = 4, unpaired t-test, t (6) = 12.8, p = <0.0001;
and an approximate 94% reduction for GluA2, n = 4, unpaired t-test, t (6) = 40.5, p = <0.0001)
(Figure 4F). Taken together, this data demonstrates that LRFN2 and AMPA receptors show overlap-
ping distributions on the cell surface of dendrites, and that LRFN2 associates with the GluA1 and
GluA2 subunits of AMPA receptors through an interaction principally mediated by its extracellular
LRR and Ig domains.
To investigate whether LRFN2 suppression affects the surface levels of GluA1 and GluA2, we
turned to an immunofluorescence analysis in primary neurons. To relate this single-cell analysis with
the previously described population-based biochemical quantification of cell surface AMPA recep-
tors (see Figure 3E), we suppressed SNX27 expression through transduction of SNX27 targeting
shRNA into primary rat cortical neuronal cultures. After 7 days of culturing, the intensity of GluA1
and GluA2 staining were quantified with antibodies that specifically detect extracellular epitopes of
these subunits. Consistent with the aforementioned biochemical analysis this revealed a significant
reduction in cell surface GluA1 and GluA2 staining upon SNX27 suppression (GluA1: an approximate
16% reduction, n = 50, Mann Whitney test, U (730), p = 0.0003; GluA2: an approximate 34% reduc-
tion n = 50, Mann Whitney test, U (632), p < 0.0001) (Figure 5A). In a parallel analysis, the suppres-
sion of LRFN2 expression (Figure 5B) also caused a significant reduction in GluA2 surface
Figure 3 continued
proteins of DIV19 rat cortical neurons transduced with either a control or SNX27 shRNA for: (D) Endogenous surface GluA1 and GluA2. Total levels of
endogenous SNX27 are also shown. Quantification from four independent experiments (n = 4). Data expressed as a percentage of the control shRNA
and analysed by an unpaired t-test. (E) Endogenous surface Transferrin receptor. Total levels of endogenous SNX27 are also shown. Quantification from
four independent experiments (n = 4). Data expressed as a percentage of the control shRNA and analysed by an unpaired t-test. (F) Endogenous
surface LRFN2. Total levels of endogenous SNX27 are also shown. Quantification from six independent experiments (n = 6). Data expressed as a
percentage of the control shRNA and analysed by an unpaired t-test. (G) Immunofluorescence staining of internalised LRFN2 in H4 cells transduced
with either control or SNX27 shRNA. Cells were transfected with mCherry-LRFN2 and after 24 hr the surface LRFN2 labelled using an mCherry antibody.
The labelled mCherry-LRFN2 was allowed to internalise for 2 hr before fixation and permeabilisation. Cells were co-stained with LAMP2 as a lysosome
marker. Scale bars, 10 mm. Quantification of colocalisation of LRFN2 (pseudocoloured in magenta) and LAMP2 (pseudocoloured in green) from three
independent experiments (n = 30 cells analysed). Data analysed by an unpaired t-test. In all figures error bars represent mean ± SEM. ****, P0.001; **,
P0.01; *, P0.05.
The online version of this article includes the following source data for figure 3:
Source data 1. Original immunoblots.
Source data 2. Data for Figure 3C – G.
McMillan, Banks, et al. eLife 2021;10:e59432. DOI: https://doi.org/10.7554/eLife.59432 9 of 32








































































































































































































































































LRR Ig FNIII TM PDZbmLRFN2 FL 
















































































































































































































































Figure 4. LRFNs interact with AMPA receptors. (A) Immunofluorescence staining of endogenous surface GluA1 and GluA2 in DIV20 rat hippocampal
neurons transduced with mCherry-LRFN2 expressing sindbis virus. An mCherry antibody was used to stain for surface LRFN2 expression followed by a
far-red labelled secondary antibody (pseudocoloured in magenta). Cells were co-stained with antibodies against extracellular epitopes of the
endogenous AMPA receptor subunits GluA1 and GluA2 (shown in green) Scale bars, 20 mm. White boxes indicate the 20 mm section zoomed in. Yellow
Figure 4 continued on next page
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expression (an approximate 40% reduction, n = 50, Mann Whitney test, U (556), p < 0.0001) but,
interestingly, had no significant effect on the cell surface expression of GluA1 (n = 50, Mann Whitney
test, U (1228), p = 0.8813) (Figure 5C).
To assess further the trafficking of the AMPA receptor subunit GluA2, we analysed the internalisa-
tion of GluA2 after suppression of SNX27 or LRFN2 in primary neurons. After 7 days of culturing
with shRNA treatment, surface GluA2 receptor subunits were labelled with an antibody that specifi-
cally detected the extracellular epitope of the GluA2 subunit. The GluA2 was allowed to internalise
for 1 hr before fixation. The antibody remaining on the surface was labelled with a secondary Alexa
Fluor 405 antibody. After permeabilisation, the neurons were co-stained with VPS35 to label the
endosome or LAMP1 to label the lysosome and internalised receptors were detected using a distinct
secondary Alexa Fluor 647 antibody. The intensity of internalised GluA2 was quantified in the cell
body and proximal dendrites and found to be significantly increased after suppression of both
SNX27 (an approximate 43% increase, n = 58, Mann Whitney test, U (827), p < 0.0001) and LRFN2
(an approximate 14% increase, n = 58, Mann Whitney test, U (1198), p = 0.0073) with the GluA2
overlapping with both VPS35 and LAMP1 (Figure 6A, B, C). This suggests that suppression of
SNX27 or LRFN2 perturbs the recycling of GluA2, increasing its retention time in the endo-lysosomal
system. Overall, these data establish a biochemical and functional connection between LRFN2 and
the SNX27-dependent membrane trafficking of the AMPA receptor subunit GluA2.
In vivo suppression of SNX27 and LRFN2 affects ex vivo AMPA
receptor activity in the hippocampus
In isolated neuronal cultures SNX27 and LRFN2 suppression regulates AMPA receptor membrane
trafficking and cell surface expression. To relate these phenotypes to the functional activity of synap-
tic AMPA receptors, we turned to an electrophysiological analysis in ex vivo slices. Here, we stereo-
taxically injected one dorsal hippocampal hemisphere of an adult rat with lentivirus encoding for
specific targeting shRNAs (targeting either SNX27 or LRFN2) and injected the other hemisphere of
the same animal with a control non-targeting shRNA lentivirus (all lentiviruses were engineered to
express GFP in order to visualise the transduced area). Six to eight weeks after surgery, we prepared
ex vivo hippocampal slices and performed electrophysiological recordings by stimulating Schaffer
collaterals and recording field excitatory postsynaptic potentials (fEPSPs) in the stratum radiatum of
GFP-positive regions of CA1 (Figure 7A). Input-output curves showed that SNX27 shRNA treatment
profoundly decreased excitatory synaptic transmission compared to the non-targeting control
shRNA (two-way repeated-measures ANOVA, between subjects, F (1,19) = 22.3, p = 0.0001)
(Figure 7B and C). Importantly, LRFN2 shRNA treatment also significantly decreased excitatory syn-
aptic transmission compared to the non-targeting control shRNA (two-way repeated-measures
ANOVA, between subjects F (1,12) = 6.7, p = 0.024) (Figure 7D and E). A direct comparison of
LRFN2 and SNX27 phenotypes revealed that SNX27 produced a larger reduction in glutamatergic
transmission than LRFN2 suppression (two-way repeated-measures ANOVA, between subjects F
(1,16) = 4.6, p = 0.047) (Figure 7F), whereas there was no difference in transmission between the
two non-targeting control shRNAs (F (1,15) = 0.95, p = 0.35), suggesting that SNX27, as well as
Figure 4 continued
arrows show points of overlap. (B) Representative fluorescence intensity plots of the 20 mm zoomed in sections for surface LRFN2 and GluA1 in A
(region i). (C) Representative fluorescence intensity plots shown of the 20 mm zoomed in sections for surface LRFN2 and GluA2 in (A; region iii). (D)
Fluorescence-based western analysis after GFP-Trap immunoprecipitation of full-length SEP-GluA1 or SEP-GluA2 co-expressed with full-length
mCherry-LRFN1, mCherry-LRFN2 or mCherry-LRFN4 in HEK293T cells. (E) Schematic of LRFN2 constructs mCherry-LRFN2 FL (full-length) and
N-terminal mutants. LRR, leucine-rich repeat; NT/CT, N/C-terminal domains of LRR; Ig, immunoglobulin domain; FNIII, fibronectin type-III; TM,
transmembrane; PDZbm, PDZ binding motif. (F) Fluorescence-based western analysis after RFP-Trap immunoprecipitation of mCherry-LRFN2 wild-type
(LRFN2 FL) or N-terminal mutants co-expressed with full-length SEP-GluA1 or myc-GluA2 in HEK293T cells. Quantification from four independent
experiments (n = 4). Data expressed as a percentage of the full-length mCherry-LRFN2 and analysed by an unpaired t-test. In all figures error bars
represent mean ± SEM. ****, P0.0001; *, P0.05.
The online version of this article includes the following source data for figure 4:
Source data 1. Original immunoblots.
Source data 2. Data for Figure 4F.
McMillan, Banks, et al. eLife 2021;10:e59432. DOI: https://doi.org/10.7554/eLife.59432 11 of 32
Research article Cell Biology Neuroscience
A B
GluA2 GluA2
Control shRNA SNX27 shRNA
GluA1 GluA1










































































































































Figure 5. SNX27 and LRFN2 suppression affects surface AMPA receptor expression. (A) Immunofluorescence staining of endogenous surface GluA1
and GluA2 in DIV19 rat hippocampal neurons transduced with either control or SNX27 shRNA. Scale bars, 20 mm. White boxes indicate the 20 mm
section zoomed in. Quantification of surface GluA1 and GluA2 from five independent experiments (n = 50 neurons analysed). Data analysed by a Mann-
Whitney U test. (B) Immunofluorescence staining of endogenous surface GluA1 and GluA2 in DIV19 rat hippocampal neurons transduced with either
control or LRFN2 shRNA. Scale bars, 20 mm. White boxes indicate the 20 mm section zoomed in. Quantification of surface GluA1 and GluA2 from five
independent experiments (n = 50 neurons analysed). Data analysed by a Mann-Whitney U test. In all figures error bars represent mean ± SEM. ****,
p0.0001; ***, p0.001; ns, not significant. Fluorescence-based western analysis shown of DIV19 rat cortical neurons transduced with either control or
LRFN2 shRNA for endogenous LRFN2. Actin was used as a protein load control.
Figure 5 continued on next page
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affecting LRFN2 expression, may also be regulating other LRFNs and/or other synaptic proteins that
can influence AMPA receptor activity. We are however cautious in over-interpreting such a
comparison.
Finally, loss of SNX27 has previously been shown to impair induction of hippocampal LTP
(Wang et al., 2013). Therefore, we asked whether LRFN2 suppression also affects activity-depen-
dent synaptic plasticity. Following high-frequency stimulation (HFS), we observed that the non-tar-
geting control-treated slices exhibited robust LTP (paired t-test, t (5) = 3.9, p = 0.011) (Figure 7G
and H) while no detectable LTP was induced in the LRFN2 shRNA-treated slices (paired t-test, t (4)
= 1.8, p = 0.15) (Figure 7G and I) indicating that LRFN2 suppression attenuates the induction of
LTP. Taken together these data indicate that LRFN2 plays an important role in the functional expres-
sion and activity of synaptic AMPA receptors and reveals a new player in the complex SNX27-medi-
ated regulation of AMPA receptor trafficking.
Discussion
Patients lacking SNX27 expression or expressing predicted damaging inherited SNX27 variants dis-
play a range of neuronal phenotypes that include developmental delays, abnormal neurocognitive
function, epilepsy, various types of seizure, and subcortical white matter abnormalities
(Damseh et al., 2015; Parente et al., 2020). While known SNX27-associated neuronal integral pro-
teins, such as NMDA receptors (Cai et al., 2011; Wang et al., 2006), 5-HT4 receptor
(Joubert et al., 2004), metabotropic glutamate receptor 5 (mGluR5) (Lin et al., 2015), neuroligin 2
(Binda et al., 2019; Halff et al., 2019), and Kir3 channels (Lunn et al., 2007), have provided some
insight into these complex phenotypes our unbiased quantitative identification of the neuronal
SNX27 interactome has revealed an additional cohort of integral neuronal proteins that associate
with SNX27. Besides LRFN2 (see discussion below), many of these proteins function in an array of
neuronal activities: the high affinity glutamate transporter, SLC1A3, and the sodium bicarbonate co-
transporter, SLC4A7, are associated with controlling glutamate neurotoxicity Rothstein et al., 1996;
Watase et al., 1998; Jen et al., 2005; Park et al., 2019; SLC6A11, a sodium-dependent trans-
porter, uptakes GABA and modulates GABAergic tone Borden, 1996; KCNT2, an outward rectifying
potassium channel, is associated with early infantile epileptic encephalopathies Bhattacharjee et al.,
2003; Gururaj et al., 2017; KIDINS220, a scaffold in neurotrophin signalling, is associated with spas-
tic paraplegia and intellectual disability Kong et al., 2001; DDD Study et al., 2016; and ADAM22 is
a receptor for the neuronal secreted protein LGI1 (Fukata, 2006), the product of the causative gene
for autosomal dominant partial epilepsy with auditory features (Muona et al., 2016). This significant
expansion in the neuronal targets for SNX27-mediated endosomal sorting has therefore broadened
our understanding of those integral proteins whose perturbed cell surface expression may underly
the complex neurological phenotypes observed in SNX27-associated pathologies.
A major functional role for neuronal SNX27 is as an established regulator of postsynaptic AMPA
receptor trafficking (Wang et al., 2013; Loo et al., 2014; Hussain et al., 2014). AMPA receptors
are one of the major types of ionotropic glutamate receptors present at the postsynaptic density of
excitatory synapses and, consequently, perturbed AMPA receptor trafficking has been implicated in
numerous neurological and psychiatric disorders (Henley and Wilkinson, 2016, Shankar et al.,
2008, Shepherd and Huganir, 2007, Walsh et al., 2002, Grooms et al., 2000, Yamashita and
Kwak, 2014). Four core AMPA receptor subunits, GluA1 through to GluA4, combine to produce
functionally diverse homo- and hetero-tetrameric channels which drive fast excitatory synaptic trans-
mission (Hollmann and Heinemann, 1994, Henley and Wilkinson, 2016). AMPA receptors utilise
membrane trafficking pathways to dynamically regulate their number, composition, and biophysical
properties at the postsynaptic membrane during the modulation of synaptic strength associated
with learning and memory (Henley and Wilkinson, 2016; Diering and Huganir, 2018; Huganir and
Figure 5 continued
The online version of this article includes the following source data for figure 5:
Source data 1. Original immunoblots.
Source data 2. Data for Figure 5A and B.
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Figure 6. Suppression of SNX27 or LRFN2 increases AMPA receptors in the endo-lysosomal system. (A–B) Immunofluorescence staining of endogenous
internalised GluA2 (pseudocoloured in green) in DIV19 rat hippocampal neurons transduced with either control, SNX27 or LRFN2 shRNA. Surface
labelled GluA2 was allowed to internalise for 1 hr before fixation and permeabilisation. Scale bars, 20 mm. Zoomed in images of the cell body (Yellow
boxes). Scale bars, 5 mm. For clarity only the internalised GluA2 images are shown. The surface GluA2 expression can be found in Figure 6—figure
Figure 6 continued on next page
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Nicoll, 2013). At the mechanistic level, the regulation of AMPA receptors by SNX27 is considered to
arise from the PDZ domain of SNX27 directly binding to the PDZ binding motifs present in the car-
boxy-terminal tails of AMPA receptor subunits. However, using unbiased proteomics and biochemi-
cal validation coupled with in cellulo and ex vivo analysis, we have presented evidence consistent
with SNX27 regulating the surface expression and activity of AMPA receptors through association
with the synaptic adhesion protein LRFN2 (Figure 8). LRFN2 belongs to the LRFN family, also known
as synaptic adhesion-like molecules (SALMs), and whilst these proteins have been associated with
inhibitory synapses (Li et al., 2018) and at the pre-synapse (Brouwer et al., 2019), their function has
principally been linked with excitatory synapses (Ko et al., 2006; Morimura et al., 2006;
Wang et al., 2006; Lie et al., 2018; Mah et al., 2010; Loh et al., 2016). In proposing LRFN2 as an
accessory protein in the dynamic AMPA receptor trafficking code (Diering and Huganir, 2018), our
data adds to the complex regulation of AMPA receptor-mediated synaptic transmission and
plasticity.
We have established that LRFN2 directly interacts with SNX27 and that this is required for its traf-
ficking to the plasma membrane and away from degradation in the lysosome. In addition, we have
shown that LRFN2 associates with the AMPA receptor subunits GluA1 and GluA2, interactions that
are principally governed by the extracellular LRR and Ig domains of LRFN2. This is consistent with
these domains mediating protein:protein interactions, most notably for the trans-synaptic interac-
tions of LRFNs with type-II receptor tyrosine phosphatases (Lin et al., 2018). In the hippocampus
the major forms of AMPA receptors include GluA1/2 and GluA2/3 heteromers, and GluA1 homo-
mers, with the differential trafficking of GluA1-containing and GluA1-lacking receptors having impor-
tant implications in transmission and plasticity (Diering and Huganir, 2018; Huganir and Nicoll,
2013; Wenthold et al., 1996). Our data indicates that LRFN2 helps maintain surface expression of
GluA1-lacking receptors, but suggests that other pathways that also rely on SNX27 may exist to
maintain surface expression of GluA1-containing receptors. Our focus in this study was LRFN2 as it
was the only LRFN retained through our high stringency data filtering, and because defects in
LRFN2 have been implicated in various neurological conditions, consistent with an important role in
brain development, function, and cognition (Morimura et al., 2017; Rautiainen et al., 2016;
Thevenon et al., 2016). However, given that LRFN1 and LFRN4 also associated with SNX27 and
contain an optimal PDZ binding motif for binding to the SNX27 PDZ domain, we consider that the
endosomal sorting of these proteins will also by mediated by SNX27 and that further studies into
LRFN1 and LRFN4 are therefore likely to provide additional insights into SNX27-associated patholo-
gies. Interestingly, LRFN1 has also been shown to interact with AMPA receptors on the synaptic sur-
face (Morimura et al., 2017). It is therefore tempting to speculate that redundancies between the
LRFN proteins may explain why GluA1-containing receptors are not affected after LRFN2
suppression.
Using electrophysiology in ex vivo slices, we have shown that suppression of SNX27 leads to a
dramatic loss of AMPA receptor-mediated synaptic activity, validating our biochemical data showing
reduced surface AMPA receptor expression. This supports previous findings showing reduced
AMPA receptor-mediated postsynaptic currents in SNX27+/- mice (Wang et al., 2013). Importantly,
we have also shown that LRFN2 depletion caused a loss of AMPA receptor-mediated synaptic activ-
ity, consistent with a role for LRFN2 in SNX27-dependent AMPA receptor trafficking. We also
observed an attenuated activity-dependent hippocampal LTP upon LRFN2 suppression, which sup-
ports the study of Li and colleagues who reported a reduction of LTP in an LRFN2 knockout mouse
model (Li et al., 2018). In contrast, Morimura and colleagues reported an increase in silent synapses
Figure 6 continued
supplement 1. (A) Cells were co-stained with VPS35 (pseudocoloured in magenta) as an endosomal marker. (B) Cells were co-stained with LAMP1
(pseudocoloured in magenta) as a lysosome marker. (C) Quantification of internalised GluA2 intensity from five independent experiments (n = 58
neurons analysed). The mean intensity of GluA2 was measured from the cell body and proximal dendrites. Data analysed by a Mann-Whitney U test. In
all figures error bars represent mean ± SEM. ****, P0.0001; **, P0.01.
The online version of this article includes the following source data and figure supplement(s) for figure 6:
Source data 1. Data for Figure 6C.
Figure supplement 1. Suppression of SNX27 or LRFN2 increases AMPA receptors in the endo-lysosomal system.
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Figure 7. In vivo suppression of SNX27 and LRFN2 affects ex vivo AMPA receptor activity in the hippocampus. (A) Representative infrared image of a
transduced rat dorsal hippocampal slice expressing the control shRNA lentivirus showing placement of electrodes to record Schaffer collateral
responses. Inset (i) shows GFP fluorescence of CA1 region. Animals were left for 6–8 weeks with the control shRNA injected into one hemisphere and
either SNX27 or LRFN2 shRNA into the other hemisphere. (B) Input-output curves from SNX27 and control shRNA treated slices. Quantification from six
Figure 7 continued on next page
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and an enhancement of LTP in another LRFN2 knockout mouse model (Morimura et al., 2017). The
distinct methodology used in our study, post-development suppression of LRFN2 compared with
developmental knockout of LRFN2, may in part explain these differences.
It is well established that AMPA receptors can interact with a multitude of transmembrane pro-
teins to stabilise and retain their expression at the postsynaptic density, including scaffolding pro-
teins, synaptic adhesion molecules, and auxiliary subunits, such as the transmembrane AMPA
receptor regulatory proteins (TARPs) and cornichon-like proteins CNIH2/CNIH3 (Schwenk et al.,
2009; Coombs and Cull-Candy, 2009). Whilst we have shown that LRFN2, analogous to these auxil-
iary proteins, plays important roles in the targeting of AMPA receptors to the post-synapse, we have
not examined the question of whether LRFN2 clusters AMPA receptors into slots at the postsynaptic
density (Henley and Wilkinson, 2016) nor have we investigated the trafficking of LRFN2 through
the biosynthetic pathway and how this may regulate LRFN2 surface levels (Seabold et al., 2012).
The PDZ binding motif present in LRFN1, LRFN2 and LRFN4 can associate with many other PDZ
domain-containing proteins including the synaptic scaffolding protein PSD-95 (Ko et al., 2006;
Morimura et al., 2006; Nam et al., 2011; Wang et al., 2006), suggesting that LRFNs could also
have a role in the anchoring and stability of AMPA receptors at the synaptic surface. It is possible
that LRFNs interact with the AMPA receptor subunits through their extracellular LRR and Ig domains
and PSD-95 through their PDZ binding motifs to stabilise AMPA receptors at the synaptic surface
(Figure 8). This would be an interesting avenue to explore further.
Interestingly, NMDA receptors, which are also required for excitatory transmission and synaptic
plasticity, interact with both SNX27 and LRFN2 (Wang et al., 2006; Thevenon et al., 2016;
Morimura et al., 2006; Cai et al., 2011; Wang et al., 2013; Clairfeuille et al., 2016). The associa-
tion of SNX27 with LRFN2 may therefore play multiple roles in regulating excitatory transmission
through regulating surface expression of glutamate receptors at the synaptic surface.
LRFN2 is increasingly being linked to a range of neurological conditions including antisocial per-
sonality disorder (Rautiainen et al., 2016), autism (Morimura et al., 2017), schizophrenia
(Morimura et al., 2017), working memory deficits, and learning disabilities (Thevenon et al., 2016).
A recent proteomic screen on pre-frontal post-mortem tissue also revealed that LRFN2 protein
expression was significantly decreased in people with Alzheimer’s disease, Parkinson’s disease with
dementia, and dementia with Lewy bodies, further highlighting the importance of LRFN2 for neuro-
nal function (Bereczki et al., 2018). LRFN2 had the highest level of reduction compared to other
synaptic proteins in all three forms of dementia, and its loss was strongly associated with rate of cog-
nitive decline (Bereczki et al., 2018). Our data demonstrating that LRFN2 can control AMPA recep-
tor activity therefore provides additional insight into the role of LRFN2 in these conditions.
In summary, we have identified LRFN2 as a high-affinity neuronal interactor of SNX27 that is
required for AMPA receptor-mediated synaptic transmission. Suppression of SNX27 leads to a
reduction in LRFN2 expression which results in a loss of surface expression of GluA2 and, corre-
spondingly, a loss of synaptic activity (Figure 8). The link between SNX27, LRFN2, and AMPA recep-
tors provides a new point of control for AMPA receptor-mediated synaptic transmission and
plasticity and provides additional insight into the association of LRFN2 and SNX27 with many neuro-
logical and psychiatric conditions.
Figure 7 continued
animals (n = 10 recordings) for the control and five animals (n = 11 recordings) for the SNX27 shRNA. Data analysed by a two-way repeated-measures
ANOVA. (C) Representative traces of the recordings from (B). (D) Input-output curves from LRFN2 and control shRNA-treated slices. Quantification from
five animals (n = seven recordings) for the control and five animals (n = seven recordings) for the LRFN2 shRNA. Data analysed by a two-way repeated-
measures ANOVA. (E) Representative traces of the recordings from (D). (F) Input-output curves comparing SNX27 and LRFN2 shRNA treatment. (G) LTP
response following high frequency stimulation (HFS) at t = 0. Quantification from five animals (n = six recordings) for the control and four animals (n =
five recordings) for the LRFN2 shRNA. (H) Representative traces and quantification of the LTP response after treatment with the control shRNA (follow-
up is the final 10 min of the recording). Control slices underwent LTP with data analysed by a paired t-test. (I) Representative traces and quantification
of the LTP response after treatment with the LRFN2 shRNA. LRFN2 shRNA treated slices were not significantly potentiated. In all figures error bars
represent mean ± SEM. ****, p0.0001; *, p0.05; ns, not significant.
The online version of this article includes the following source data for figure 7:
Source data 1. Data for Figure 7B - I.
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Materials and methods
Plasmids
The intracellular C-terminal tails of GluA1 (amino acids 827–907), GluA2 (amino acids 834–883),
GluA3 (amino acids 839–888), and GluA4 (amino acids 835–902) were cloned from rat whole brain
cDNA into the vector pEGFP-C3. The intracellular C-terminal tails of wild type human LRFN1,
LRFN2, LRFN3, SLC1A3, and SLC4A7 (last 40 amino acids) were cloned from HeLa cDNA into the
GluA1/GluA2 GluA2/GluA3 LRFN2



















































Figure 8. SNX27 regulation of AMPA receptor trafficking through LRFN2 It is well established that SNX27 suppression results in a loss of AMPA
receptor expression and activity through a mechanism that evokes the direct sequence-dependent recognition of internalised AMPA receptors by
endosome associated SNX27 (1). In the absence of SNX27, internalised AMPA receptors fail to be recycled and enter the lysosomal degradative
compartment. This missorting leads to an overall reduction in AMPA receptor expression at the cell surface. Our data proposes that LRFN2 acts as a
‘bridging’ factor in SNX27-mediated AMPA receptor trafficking (2). Here, internalised LRFN2 directly associates with SNX27 through its PDZ binding
motif (PDZbm) and is a classical cargo for SNX27-dependent retrieval and recycling to the synaptic cell surface. Upon SNX27 suppression, internalised
LRFN2 is missorted to lysosomes where it undergoes degradation, leading to a reduction in LRFN2 levels at the synaptic surface. LRFN2 associates with
AMPA receptors and LRFN2 suppression leads to AMPA receptor missorting into the degradative pathway. Taken together, we propose that the
association of LRFN2 with AMPA receptors is required for the SNX27-dependent endosomal recycling of GluA1-lacking AMPA receptors. LRFN2 may
also display properties of an ‘auxiliary’ protein in aiding the retrieval and recycling of internalised AMPA receptors through the SNX27-positive
endosomal compartment and, in addition, may function as an adhesion molecule to anchor and stabilise AMPA receptor expression at the cell surface.
EE, early endosome; LE, late endosome.
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vector pEGFP-C1. The human LRFN4 (last 40 amino acids) was cloned from LRFN4 cDNA
(MHS6278-202832013, GE Healthcare) and the human LRFN5 (last 40 amino acids) generated by
combining oligonucleotides ordered from Eurofins genomics. The DPDZbm mutants (missing the last
three amino acids) were cloned either directly from cDNA or by site-directed mutagenesis of the
wild type plasmids. The LRFN2(pE786A) and LRFN2(pV789A) mutants were generated using site-
directed mutagenesis of the LRFN2 wild-type plasmid. The LRFN2 full length construct and N-termi-
nal mutants were cloned from HeLa cDNA and inserted into a pmCherryC1 vector containing the
LRFN1 signal peptide upstream of the mCherry tag. Flag-tagged rat SNX27 was produced by PCR
amplification of the SNX27 coding sequence from cDNA produced from PC12 cells with a FLAG tag
added to the forward primer. The resulting PCR product was then cloned into the vector pcDNA3.1.
SEP-GluA1 (Blanco-Suarez and Hanley, 2014) (64942; Addgene), SEP-GluA2 (Ashby et al., 2004)
(64941; Addgene), and N-terminally myc-tagged GluA2 (Leuschner and Hoch, 1999) constructs
have been reported previously.
Cell culture
All cells were cultured in a humidified incubator at 37˚C and 5% CO2. HEK293T (American Type Cul-
ture Association (ATCC)) and H4 cells (a gift from Dr Helen Scott and Professor James Uney) were
maintained in DMEM (D5796; Sigma-Aldrich) supplemented with 10% foetal bovine serum (F7524;
Sigma-Aldrich). For the GFP/RFP-based immunoprecipitations, HEK293T cells were transfected with
GFP/RFP- expressing constructs using polyethyleneimine (PEI) (Sigma-Aldrich). BHK-21 cells (ATCC)
were maintained in Alpha MEM (22561–021, Gibco) supplemented with 5% foetal bovine serum
(F7524; Sigma-Aldrich) and 1% Penicillin/Streptomycin (P0781, Sigma-Aldrich).
Primary neuronal cultures were prepared from embryonic day E18 Wistar rat brains as previously
described (Martin and Henley, 2004). In brief, dissociated cortical cells were grown in six well
dishes (500,000 cells/well), and hippocampal cells on 22 mm glass coverslips (150,000 cells/coverslip)
coated with poly-L-lysine (P2636; Sigma-Aldrich) in 2 ml plating medium (Neurobasal medium
(21103–049, Gibco) supplemented with 5% horse serum (H1270), 2% B27 (17504–044, Gibco) and
1% Glutamax (35050–038)) which was exchanged for 2 ml feeding medium 2 hr after plating (Neuro-
basal medium (21103–049, Gibco), 2% B27 (17504–044, Gibco), and 0.4% Glutamax (35050–038)).
Cells were then fed with an additional 1 ml of feeding medium 7 days after plating.
Lentivirus and Sindbis virus production
For lentivirus production, shRNAs driven by a H1 promoter were generated for the knockdown of
rat SNX27 (target sequence 5’-aagaacagcaccacagaccaa-3’) (Binda et al., 2019), human SNX27 (tar-
get sequence 5’- aagaacagtactacagaccaa-3’), rat LRFN2 (target sequence 5’-acgacgaggtactgattta-
3’), and a control (non-targeting sequence 5’-aattctccgaacgtgtcac-3’). Oligonucleotides were cloned
into a modified pXLG3-GFP viral vector and co-transfected into a 15 cm dish of HEK293T cells with
the helper plasmids Pax2/p8.91 and pMDG2 using PEI. For primary culture, the viruses were har-
vested 72 hr after transfection, spun down at 4000 rpm for 10 min at room temperature (RT) and fil-
tered through 0.45 mm filters before being stored at  70˚C. Neurons were transduced with shRNA
viruses on DIV12 and left for 7 days before analysis. Only those experiments where knockdown
resulted in more than 85% reduction of the protein of interest were used for analysis. For in vivo
injections, the lentiviral constructs were modified to include a Woodchuck Hepatitis Virus Posttran-
scriptional Regulatory Element (WPRE) to increase the GFP expression and the amount of HEK293T
cells were scaled up to 10 x 15 cm dishes/virus. The media was harvested 48 hr after transfection,
spun down at 4000 rpm for 10 min at RT and filtered through 0.45 mm filters. The filtered superna-
tant was then centrifuged in JA20 tubes at 6000 rpm overnight (O/N) at 4˚C (Avanti J-25, Beckman
Coulter). The following day the viral pellet was resuspended in 5 ml PBS and centrifuged at 20,000
rpm for 90 min at 4˚C (Optima XL-100K, Beckman Coulter). The pellet was then resuspended in the
required volume of PBS before being aliquoted and stored at  70˚C.
For sindbis virus production, full-length human SNX27 and LRFN2 were cloned into the pSinRep5
plasmid. GFP-SNX27 was amplified from pEGFP-C1 and the resulting PCR product cloned into pSin-
Rep5. The LRFN2 was subcloned from a pmCherryC1 vector which contained a mCherry fluorescent
tag immediately after a N -terminal signal peptide (LRFN1 signal peptide) followed by full-length
LRFN2. GFP- and mCherry- expressing pSinRep5 plasmids were created as controls. Five mg of in
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vitro-transcribed RNA (2.5 mg of SNX27/LRFN2 RNA and 2.5 mg of the defective helper plasmid) was
electroporated into 0.6x107 BHK-21 cells using a Gene Pulser II electroporation system (BioRad) in a
gene pulser cuvette (0.2 cm gap). The electroporation conditions were set as follows: voltage; 1.5
kV, capacitance; 25 mF for a period of 0.7–0.8 ms. The viruses were harvested 36–48 hr after electro-
poration before being stored at  70˚C. Neurons were transduced with sindbis viruses on DIV19/20
and left for 18–24 hr before analysis.
TMT proteomics
Immunoisolated samples were reduced (10 mM TCEP, 55˚C for 1 hr), alkylated (18.75 mM iodoaceta-
mide, RT for 30 min) and then digested from the beads with trypsin (2.5 mg trypsin: 37˚C, O/N). The
resulting peptides were then labelled with TMT six plex reagents according to the manufacturer’s
protocol (Thermo Scientific) and the labelled samples pooled and desalted using SepPak cartridges
according to the manufacturer’s instructions (Waters). Eluate from the SepPak cartridge was evapo-
rated to dryness and resuspended in 1% formic acid prior to analysis by nano-LC MSMS using an
Ultimate 3000 nano-LC system in line with an LTQ-Orbitrap Velos mass spectrometer (Thermo
Scientific).
In brief, peptides in 1% (vol/vol) formic acid were injected onto an Acclaim PepMap C18 nano-
trap column (Thermo Scientific). After washing with 0.5% (vol/vol) acetonitrile 0.1% (vol/vol) formic
acid peptides were resolved on a 250 mm  75 mm Acclaim PepMap C18 reverse phase analytical
column (Thermo Scientific) over a 150 min organic gradient, using seven gradient segments (1–6%
solvent B over 1 min., 6–15% B over 58 min., 15–32% B over 58 min., 32–40% B over 5 min., 40–90%
B over 1 min., held at 90% B for 6 min and then reduced to 1% B over 1 min.) with a flow rate of 300
nl min 1. Solvent A was 0.1% formic acid and Solvent B was aqueous 80% acetonitrile in 0.1% formic
acid. Peptides were ionised by nano-electrospray ionisation at 2.0 kV using a stainless-steel emitter
with an internal diameter of 30 mm (Thermo Scientific) and a capillary temperature of 250˚C. Tandem
mass spectra were acquired using an LTQ- Orbitrap Velos mass spectrometer controlled by Xcalibur
2.1 software (Thermo Scientific) and operated in data-dependent acquisition mode. The Orbitrap
was set to analyse the survey scans at 60,000 resolution (at m/z 400) in the mass range m/z 300–
1800 and the top 10 multiply charged ions in each duty cycle selected for MS/MS fragmentation
using higher energy collisional dissociation (HCD) with normalised collision energy of 45%, activation
time of 0.1 ms and at a resolution of 7500 within the Orbitrap. Charge state filtering, where unas-
signed precursor ions were not selected for fragmentation, and dynamic exclusion (repeat count, 1;
repeat duration, 30 s; exclusion list size, 500) were used.
The raw data files were processed and quantified using Proteome Discoverer software v2.1
(Thermo Scientific) and searched against the UniProt Rat database (downloaded January 2019:
35759 entries) using the SEQUEST algorithm. Peptide precursor mass tolerance was set at 10 ppm,
and MS/MS tolerance was set at 0.6 Da. Search criteria included oxidation of methionine (+15.995
Da), acetylation of the protein N-terminus (+42.011 Da) and Methionine loss plus acetylation of the
protein N-terminus ( 89.03 Da) as variable modifications and carbamidomethylation of cysteine
(+57.021 Da) and the addition of the TMT mass tag (+229.163 Da) to peptide N-termini and lysine
as fixed modifications. Searches were performed with full tryptic digestion and a maximum of two
missed cleavages were allowed. The reverse database search option was enabled, and all data was
filtered to satisfy false discovery rate (FDR) of 5%. The mass spectrometry proteomics data have
been deposited to the ProteomeXchange Consortium via the PRIDE partner repository (http://www.
ebi.ac.uk/pride/archive/projects/PXD026289).
Surface biotinylations
All solutions were pre-chilled to 4˚C and all steps were carried out on ice to prevent internalisation.
Fresh membrane impermeable Sulpho NHS-SS-Biotin (21331, Thermo Fisher Scientific) was dissolved
in PBS at a final concentration of 0.2 mg/ml. Neurons were washed twice in PBS before being incu-
bated with biotin for 15 mins at 4˚C. The cells were then washed in PBS before being quenched in
quenching buffer (50 mM Triz, 100 mM NaCl, pH 7.5) for 10 min at 4˚C. The cells were lysed in 2%
Triton-X-100 (X100, Sigma) plus protease inhibitor cocktail tablets (A32953, Thermo Fisher Scientific)
in PBS and a BCA assay (23225, Thermo Fisher Scientific) carried out to determine protein
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concentration. Equal protein amounts of lysate were incubated with streptavidin beads (17-5113-01,
GE Healthcare) for 1 hr at 4˚C before being washed and analysed by western blotting.
Immunoprecipitation and western blot analysis
For immunoprecipitation experiments, cells were lysed in Tris-based immunoprecipitation buffer (50
mM Tris-HCl, pH 7.4, 0.5% NP-40, and Roche protease inhibitor cocktail in ddH2O) before being
subjected to GFP/RFP-Trap beads (gta-20, rta-20, ChromoTek). For whole cell levels, cells were
lysed in 1% Triton-X-100 plus Roche protease inhibitor cocktail in phosphate buffered saline (PBS). A
BCA assay was used to determine the protein concentration.
Proteins were resolved on NuPAGE 4–12% precast gels (NP0336BOX, Invitrogen) and then trans-
ferred onto polyvinylidene fluoride (PVDF) membranes (10600029, GE Healthcare), before being
blocked in 5% milk and incubated with primary antibody O/N at 4˚C. The membrane was washed in
Tris-buffered saline plus 0.1% Tween (TBS-T) before being incubated with Alexa Fluor secondary
antibodies (680 and 800, Invitrogen). After washing in TBS-T the protein bands were visualised using
an Odyssey infrared scanning system (LI-COR Biosciences). For measuring total protein abundance
all data was normalised to the protein loading control b–actin. For both total and surface protein
abundance, the data was expressed as a percentage of the control treatment.
ITC
The rat SNX27 PDZ domain and human VPS26A proteins were purified as described previously
(Gallon et al., 2014; McMillan et al., 2016; Chan et al., 2016). Proteins were gel filtered into ITC
buffer (50 mM Tris, pH 8, and 100 mM NaCl) using a Superose 200 column. The LRFN2 peptides
were purchased from Genscript (USA) and ITC experiments were performed on a MicroCal iTC200
instrument in ITC buffer. Peptides at a concentration of 1 mM were titrated into 40 mM SNX27 PDZ
domain solutions at 25˚C (supplemented with 40 mM hVPS26A proteins when required). Data were
processed using ORIGIN to extract the thermodynamic parameters DH, Ka(1/Kd) and the stoichiome-
try n. DG and DS were derived from the relationships: DG =  RTlnKa and DG = DH   TDS.
Immunofluorescence staining
For total protein expression, neurons were fixed in 4% (vol/vol) paraformaldehyde in PBS for 15 min
at RT before being quenched in 100 mM glycine. Neurons were permeabilised and blocked in 0.1%
Triton X-100 plus 2% BSA (05482, Sigma) for 15 min at RT followed by incubation for 1 hr at RT in
the indicated primary antibodies. The neurons were then incubated with the appropriate Alexa Fluor
secondary antibodies (488, 568 and 647; Invitrogen) for 1 hr before being mounted on coverslips
with Fluoromount-G (00–4958–02; eBioscience).
For surface expression of AMPA receptors, hippocampal neurons were incubated with primary
antibodies that recognise the N-terminal epitope for 15 min at 37˚C. For surface expression of trans-
duced mCherry-LRFN2, neurons were incubated with a mCherry antibody. Neurons were then
washed in PBS before being fixed in 4% paraformaldehyde (PFA, 28908, Thermo Fisher Scientific) in
PBS for 15 min at RT and quenched in 100 mM glycine (G/0800/60, Fisher Scientific). The surface
expressed AMPA receptors were detected using Alexa Fluor 568 secondary antibodies whilst the
surface expressed LRFN2 was detected using a far red (647) Alexa Fluor secondary antibody to dis-
tinguish from total levels.
Trafficking assays
For analysing LRFN2 internalisation H4 cells transduced with shRNA were transfected using Fugene
six transfection reagent (E2691; Promega) with mCherry-LRFN2 for 24 hr. The cells were placed on
ice, washed in ice-cold PBS and left for 5 min in CO2 independent media (18045–054, Gibco) sup-
plemented with 1% foetal bovine serum (F7524; Sigma-Aldrich). Surface LRFN2 was labelled using
the anti-rabbit mCherry antibody in CO2 independent media plus 1% foetal bovine serum for 30 min
at 4˚C. The cells were washed twice in ice-cold PBS and returned to the incubator in growth media
for 2 hr to allow internalisation of the labelled LRFN2. The cells were washed in PBS before being
fixed and permeabilised in 100% methanol for 4 min at  20˚C. The cells were blocked in 1% BSA for
10 min at RT followed by incubation for 1 hr at RT with the primary antibody against LAMP2. The
neurons were then incubated with the appropriate Alexa Fluor secondary antibodies (405 for the
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labelled LRFN2 to distinguish from total and 647 for the LAMP2; Invitrogen) for 1 hr before being
mounted on coverslips with Fluoromount-G (00–4958–02; eBioscience).
For analysing GluA2 internalisation hippocampal neurons transduced with shRNA were incubated
with a GluA2 primary antibody that recognised the N-terminal epitope for 15 mins at 37˚C. The neu-
rons were then placed back into their original media in the incubator for 1 hr for the labelled GluA2
receptors to internalise. Neurons were then washed in PBS before being fixed in 4% paraformalde-
hyde (PFA, 28908, Thermo Fisher Scientific) in PBS for 5 min at RT. The antibody remaining on the
surface was labelled with a secondary Alexa Fluor 405 antibody to block secondary binding sites for
receptors that remained on the surface. The neurons were then washed in PBS, fixed again in 4%
PFA for 5 min before being permeabilised and blocked in 0.1% Triton X-100 plus 2% BSA (05482,
Sigma) for 10 min at RT followed by incubation for 1 hr at RT in the indicated primary antibodies
(VPS35 or LAMP1). The neurons were then incubated with the appropriate Alexa Fluor secondary
antibodies (568 for VPS35/LAMP1 and 647 for labelled GluA2; Invitrogen) for 1 hr before being
mounted on coverslips with Fluoromount-G (00–4958–02; eBioscience).
Image acquisition and analysis
Images were captured using a confocal laser-scanning microscope (SP5 AOBS; Leica Biosystems)
attached to an inverted epifluorescence microscope (DMI6000; Thermo Fisher Scientific). A 63, NA
1.4, oil immersion objective (Plan Apochromat BL; Leica Biosystems), and the standard SP5 system
acquisition software and detector were used. All settings were kept the same within experiments.
For the neuronal surface, immunofluorescence experiments single plane images were captured,
whereas for the trafficking experiments looking at internalised proteins Z-stacks were compiled.
To calculate the colocalisation of LAMP2 with LRFN2 in the H4 cells, Volocity was used to calcu-
late the Pearson’s correlation. Fiji ImageJ software (NIH) was used to process all neuronal images.
For colocalisation in the neurons, line traces were used across a 20 mm region of interest within the
proximal dendrites. To quantify AMPA receptor surface expression after shRNA treatment, 10 neu-
rons were imaged for each individual experiment across five independent experiments (number of
experiments N = 5; total number of neurons analysed: n = 50). The maximum fluorescence intensity
was measured across three 10 mm ROIs within the proximal dendrites and averaged for each neuron.
To quantify the internalised GluA2 intensity after shRNA treatment, 10/12 neurons were imaged for
each individual experiment across five independent experiments (number of experiments N = 5;
total number of neurons analysed: n = 58). The mean intensity was measured from the cell body and
proximal dendrites.
Viral surgical procedure
Experiments were carried out in naı̈ve male Lister Hooded rats (Envigo, UK) weighing 280–350 g at
the start of experiments. Animals were housed in groups of 2–4 under a 12 hr/12 hr light/dark cycle
with lights on 20:00-08:00 and were given ad libitum access to food and water. Sacrifice for ex-vivo
slices occurred 2–3 hr into the dark cycle. All animal procedures were conducted in accordance with
the United Kingdom Animals Scientific Procedures Act (1986) and associated guidelines. All efforts
were made to minimise suffering and number of animals used.
Each animal was injected with shRNA lentiviral vectors in the dorsal hippocampus (dHPC) of one
hemisphere and control vector in dHPC of the opposite hemisphere, with the experimenter blinded
to viral type and viruses left and right counterbalanced. Rats were anaesthetised with isoflurane (4%
induction, 2–3.5% maintenance) and secured in a stereotaxic frame with the incisor bar set 3.3 mm
below the interaural line. two burr holes per hemisphere were made in the skull at the following
coordinates with respect to bregma: anterior-posterior (AP) – 3.2 mm, mediolateral (ML) ± 2.4 mm
and AP  3.9 mm, ML ± 2.8 mm. Virus was front loaded into a 33-gauge needle attached to a 5 ml
Hamilton syringe. The needle was lowered 2.9 mm below bregma using the above AP and ML coor-
dinates and 1 ml of virus was delivered to each site at a (therefore each hemisphere received a total
of 2 mm of virus) rate of 200 nl.min 1, with the needle left in situ for 10 min after each injection.
Ex vivo slice preparation
Six to eight weeks following viral injection animals were anaesthetised with 4% isoflurane and decap-
itated. Brains were rapidly removed and placed into ice-cold sucrose cutting solution (in mM: 189
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sucrose, 26 NaHCO3, 10 D-glucose, 5 MgSO4, 3 KCl, 1.25 NaH2PO4, 0.2 CaCl2) saturated with 95%
O2/5% CO2. 350-mm-thick parasagittal hippocampal slices were prepared using a vibratome
(7000smz-2, Camden Instruments) and stored at room temperature in artificial cerebrospinal fluid
(aCSF; in mM: 124 NaCl, 26 NaHCO3, 10 D-glucose, 3 KCl, 2 CaCl2, 1.25 NaH2PO4, 1 MgSO4) satu-
rated with 95% O2/5% CO2 for 1 hr before recording. Slices were separated by hemisphere with
the experimenter blind to viral type.
Electrophysiology dHPC slices were placed into a submerged recording chamber and perfused
with 32–34˚C aCSF at a rate of ~2 ml.min 1. Wide field fluorescence was used to confirm lentiviral
transduction as indicated by GFP fluorescence. Two to 5 MW borosilicate glass electrodes (GC150-
10F, Harvard Apparatus) filled with aCSF were placed into the stratum radiatum of a GFP-positive
region of CA1 and a bipolar stimulating electrode (CBAPB50, FH-Co) was placed in adjacent stratum
radiatum to stimulate Schaffer collaterals. Recordings were obtained using a Molecular Devices Mul-
ticlamp 700A or 700B, filtered at 4 KHz and digitised at 20 KHz using WinLTP software. Paired-pulse
stimuli (50 ms inter-stimulus-interval) were delivered every 10 s using a digitimer DS2A constant volt-
age stimulator. Input-output curves were generated with a minimum of 3 stimuli at each stimulus
intensity prior to LTP experiments. LTP induction was achieved using a single tetanus of 100 stimuli
delivered at 100 Hz. Where possible two experiments per hemisphere per animal were made. Data
were acquired using WinLTP (Anderson and Collingridge, 2001).
Statistical analysis
All statistical analyses were carried out using GraphPad Prism 7. For biochemical data, a D’Agostino
and Pearson normality test was performed. For data that was normally distributed a parametric non-
paired t-test was used whereas for data not normally distributed a non-parametric Mann-Whitney U
test was used. For electrophysiological data, a Shapiro-Wilk normality test was performed, all data
were normally distributed. A two-way ANOVA or unpaired t-test was used to assess differences in
basal transmission. LTP was assessed by a paired t-test of raw fEPSP amplitudes. For all analysis
mean and standard error were calculated with *p  0.05, **p  0.01, ***p  0.001, ****p  0.0001
considered significant.
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. Supplementary file 1. A neuronal SNX27 interactome reveals new cargoes for SNX27-mediated
trafficking. (A) Raw data from TMT Interactome of SNX27 compared to the GFP control quantified
across three independent experiments (N = 3) in DIV21 rat cortical neurons. (B) Filtered TMT interac-
tome (212 proteins) showing only those proteins that were statistically significant (one-sample t-test
and Benjamini–Hochberg false-discovery rate) and over two log fold change compared to the GFP
control.
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